Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Goldman Sachs Group Inc's stake in Rhythm Pharmaceuticals, Inc. fell to 3.00% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 10, 2025
Goldman Sachs Group Inc's stake in Rhythm Pharmaceuticals, Inc. fell to 3.00%, 1,818,932 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).
- Stake
- 3.00%
- Shares
- 1,818,932
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 3.00% | 1,818,932 |
| GOLDMAN SACHS & CO. LLC | 3.00% | 1,818,932 |